Borderline epithelial tumors of the ovary: Experience of 55 patients

Loizzi,Vera; Selvaggi,Luigi; Leone,Luca; Latorre,Donatella; Scardigno,Doriana; Magazzino,Francescapaola; Cormio,Gennaro

doi:10.3892/ol.2014.2758

February-2015 Volume 9 Issue 2

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

February-2015 Volume 9 Issue 2

Full Size Image

Article

Borderline epithelial tumors of the ovary: Experience of 55 patients

Authors:
- Vera Loizzi
- Luigi Selvaggi
- Luca Leone
- Donatella Latorre
- Doriana Scardigno
- Francescapaola Magazzino
- Gennaro Cormio
View Affiliations / Copyright

Affiliations: Department of Biomedical Science and Human Oncology, University of Bari, Bari I‑70124, Italy
Pages: 912-914
|
Published online on: December 2, 2014

https://doi.org/10.3892/ol.2014.2758
Expand metrics +

Abstract

The objective of the present study was to evaluate the clinicopathological features and the survival time estimates in patients treated for borderline ovarian tumors (BOTs). A retrospective review of all patients treated for BOTs at the University of Bari (Bari, Italy) between 1991 and 2011 was performed. Data were obtained from hospital records and gynecological oncology charts. A total of 55 patients were identified. The median age was 40 years (range, 13‑79 years). The majority of the patients (85.5%) exhibited International Federation of Obstetrics and Gynecology (FIGO) stage I disease and the remainder exhibited FIGO stage II/III (7.3% in each stage). Serous histology was found in 60.0% of the cases and an elevation of the cancer antigen-125 serum level occurred in 23.6% of the cases. All patients underwent surgery and 3.7% received chemotherapy. In total, 10.9% exhibited recurrence and the median survival rate was 39 months. The median survival time and the five‑year survival rate were 42 months (range, 16‑84 months) and 97%, respectively. Therefore, BOTs have an excellent prognosis. Conservative surgery should be considered for patients of reproductive age who desire preservation of fertility. A long‑term follow‑up is highly recommended for these tumors.

View Figures

View References

1	Taylor H: Malignant and semi-malignant tumors of the ovary. Surg Gynecol Obstet. 48:204–230. 1929.
2	Hart WR and Norris HJ: Borderline and malignant mucinous tumors of the ovary. Histologic criteria and clinical behavior. Cancer. 31:1031–1045. 1973. View Article : Google Scholar : PubMed/NCBI
3	Crispens MA: Borderline ovarian tumours: a review of the recent literature. Curr Opin Obstet Gynecol. 15:39–43. 2003. View Article : Google Scholar : PubMed/NCBI
4	Skirnisdóttir I, Garmo H, Wilander E and Holmberg L: Borderline ovarian tumors in Sweden 1960–2005: trends in incidence and age at diagnosis compared to ovarian cancer. Int J Cancer. 123:1897–1901. 2008. View Article : Google Scholar
5	Sherman ME, Mink PJ, Curtis R, Cote TR, Brooks S, Hartge P and Devesa S: Survival among women with borderline ovarian tumors and ovarian carcinoma: a population-based analysis. Cancer. 100:1045–1052. 2004. View Article : Google Scholar : PubMed/NCBI
6	Bostwick DG, Tazelaar HD, Ballon SC, Hendrickson MR and Kempson RL: Ovarian epithelial tumors of borderline malignancy. A clinical and pathologic study of 109 cases. Cancer. 58:2052–2065. 1986. View Article : Google Scholar : PubMed/NCBI
7	No authors listed. Changes in definitions of clinical staging for carcinoma of the cervix and ovary: International Federation of Gynecology and Obstetrics. Am J Obstet Gynecol. 156:263–264. 1987.PubMed/NCBI
8	Serov SF, Scully RE and Solvin LH; World Health Organization. Hisological typing of ovarian tumors. International Histologic Classification of Tumors. World Health Organization; Geneva: pp. 37–41. 1973
9	Benedet JL, Bender H, Jones H III, Ngan HY and Pecorelli S: FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO Committee on Gynecologic Oncology. Int J Gynaecol Obstet. 70:209–262. 2000. View Article : Google Scholar : PubMed/NCBI
10	Morice P, Camatte S, El Hassan J, et al: Clinical outcomes and fertility after conservative treatment of ovarian borderline tumors. Fertil Steril. 75:92–96. 2001. View Article : Google Scholar : PubMed/NCBI
11	Morris RT, Gershenson DM, Silva EG, et al: Outcome and reproductive function after conservative surgery for borderline ovarian tumors. Obstet Gynecol. 95:541–547. 2000. View Article : Google Scholar : PubMed/NCBI
12	Tazelaar HD, Bostwick DG, Ballon SC, et al: Conservative treatment of borderline ovarian tumors. Obstet Gynecol. 66:417–422. 1985.PubMed/NCBI
13	Casey AC, Bell DA, Lage JM, et al: Epithelial ovarian tumors of borderline malignancy: long-term follow-up. Gynecol Oncol. 50:316–322. 1993. View Article : Google Scholar : PubMed/NCBI
14	Zanetta G, Rota S, Chiari S, et al: Behavior of borderline tumors with particular interest to persistence, recurrence, and progression to invasive carcinoma: a prospective study. J Clin Oncol. 19:2658–2664. 2001.PubMed/NCBI
15	Chan JK, Lin YG, Loizzi V, et al: Borderline ovarian tumors in reproductive-age women. Fertility-sparing surgery and outcome. J Reprod Med. 48:756–760. 2003.PubMed/NCBI
16	Lenhard MS, Mitterer S, Kümper C, et al: Long-term follow-up after ovarian borderline tumor: relapse and survival in a large patient cohort. Eur J Obstet Gynecol Reprod Biol. 145:189–194. 2009. View Article : Google Scholar : PubMed/NCBI
17	Morice P, Camatte S, Rey A, et al: Prognostic factors for patients with advanced stage serous borderline tumours of the ovary. Ann Oncol. 14:592–598. 2003. View Article : Google Scholar : PubMed/NCBI
18	Trillsch F, Ruetzel JD, Herwig U, et al: Surgical management and perioperative morbidity of patients with primary borderline ovarian tumor (BOT). J Ovarian Res. 6:482013. View Article : Google Scholar : PubMed/NCBI
19	Gotlieb WH, Soriano D, Achiron R, et al: CA 125 measurement and ultrasonography in borderline tumors of the ovary. Am J Obstet Gynecol. 183:541–546. 2000. View Article : Google Scholar : PubMed/NCBI
20	Prat J and De Nictolis M: Serous borderline tumors of the ovary: a long-term follow-up study of 137 cases, including 18 with a micropapillary pattern and 20 with microinvasion. Am J Surg Pathol. 26:1111–1128. 2002. View Article : Google Scholar : PubMed/NCBI
21	Tropé C, Kaern J, Vergote IB, Kristensen G and Abeler V: Are borderline tumors of the ovary overtreated both surgically and systemically? A review of four prospective randomized trials including 253 patients with borderline tumors. Gynecol Oncol. 51:236–243. 1993. View Article : Google Scholar : PubMed/NCBI

Journals

International Journal of Molecular Medicine

International Journal of Oncology

Molecular Medicine Reports

Oncology Reports

Experimental and Therapeutic Medicine

Oncology Letters

Biomedical Reports

Molecular and Clinical Oncology

World Academy of Sciences Journal

International Journal of Functional Nutrition

International Journal of Epigenetics

Medicine International

Borderline epithelial tumors of the ovary: Experience of 55 patients

This article is mentioned in:

Abstract

Related Articles